Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01354366 · ClinicalTrials.gov registry record
Growth and Tolerance of Hypoallergenic Formulas
A clinical trial, sponsored by Mead Johnson Nutrition.
- Completed
- Registry status
- 511
- Enrollment target
NCT01354366: Completed study, sponsored by Mead Johnson Nutrition.
NCT01354366 is a clinical trial that has completed, run by Mead Johnson Nutrition. The registered enrollment target is 511 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01354366 has completed, sponsored by Mead Johnson Nutrition.
- COMPLETED
- Registry status
- 511 participants
- Enrollment target
Study Summary
This clinical trial will evaluate two investigational hypoallergenic infant formulas with a differing protein content to determine if they provide normal growth and are well tolerated by term infants as compared to a marketed hypoallergenic formula.
Interventions
- OTHER Infant formula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 511 participants |
| Start Date | 2011-07 |
| Est. Completion | 2012-12 |
What the finished NCT01354366 record still lists
NCT01354366 is an observational study that tracks outcomes without assigning an intervention. The registered 511 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Infant formula is the first listed.
NCT01354366 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01354366 about?
NCT01354366 is a clinical study titled "Growth and Tolerance of Hypoallergenic Formulas". This clinical trial will evaluate two investigational hypoallergenic infant formulas with a differing protein content to determine if they provide normal growth and are well tolerated by term infants as compared to a marketed hypoallergenic formula.
What is the current status of trial NCT01354366?
This trial is currently completed. The enrollment target is 511 participants. The study started on 2011-07. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01354366?
The interventions under investigation include: Infant formula (OTHER).
Who is sponsoring clinical trial NCT01354366?
This trial is sponsored by Mead Johnson Nutrition, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05005403 · 512 participants · Phase 1
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) and Other Solid Tumors, Receiving Intravenous (IV) Infusion of Azirkitug (ABBV-514) Alone or in Combination With Budigalimab or Bevacizumab
- NCT05337410 · 512 participants · NA
YES: Innovative Discussion for Engagement, Achievement, and Service
- NCT06096259 · 512 participants · Phase 2
Preventing Injured Knees From osteoArthritis: Severity Outcomes
- NCT03922542 · 510 participants · Phase 2
Comparison of Standard vs. Accelerated Corneal Crosslinking
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia